EICHORCondition: Diabetic Neuropathy, Painful · Sponsor: Helixmith Co., Ltd.
The purpose of this study is to evaluate the efficacy and safety of intramuscular administration of Engensis on pain in participants with painful diabetic peripheral neuropathy in the feet and lower legs, as compared to Placebo, as a second Phase 3, well controlled study, sufficient in supporting the efficacy and safety of Engensis.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Arizona Research Center | Phoenix, Arizona, United States | — |
| Clinical Trials - Little Rock | Little Rock, Arkansas, United States | — |
| California Medical Clinic for Headache | Los Angeles, California, United States | — |
| Clinical Trials Research - Sacramento | Sacramento, California, United States | — |
| Innovative Research of West Florida, Inc. | Clearwater, Florida, United States | — |
| Gateway Clinical Trials, LLC | O'Fallon, Illinois, United States | — |
| Foot & Ankle Center of Illinois | Springfield, Illinois, United States | — |
| Clinical Research Professionals | Chesterfield, Missouri, United States | — |
| Richmond Behavioral Associates | Staten Island, New York, United States | — |
| Health Concepts | Rapid City, South Dakota, United States | — |
| Nerve and Muscle Center of Texas | Houston, Texas, United States | — |
| Futuro Clinical Trials, LLC | McAllen, Texas, United States | — |
+ 4 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04469270